Natus Medical yesterday announced that it launched BrainWatch, a point-of-care EEG solution driven by AI. Middleton, Wisconsin-based Natus said its solution brings the reliability and trust expected from the world’s largest neurodiagnostic company into critical care environments. The launch solves the needs of customers desiring a point-of-care solution that works with NeuroWorks, an EEG platform […]
Natus Medical
Natus Neuro taps Philips, Medtronic veteran as CEO
Natus Medical (Middleton, Wisconsin) recently announced that a well-known executive in the Minneapolis-St. Paul medical device hub is the new CEO of its Natus Neuro business. Chris Landon joined Natus last month after serving for four years as the president and GM of Image Guided Therapy Devices at Philips. Before Philips, Landon worked at Medtronic […]
Natus Medical closes acquisition of Micromed
Natus Medical today announced it completed the previously announced acquisition of Micromed Holdings. The deal, announced in December 2022, will add Micromed’s neurophysiology solutions to Natus Medical’s offerings. The financial details of the acquisition were not disclosed. The Micromed acquisition is the first transaction made by the Middleton, Wisconsin-based company since its $1.2 billion acquisition […]
Natus Medical to acquire Micromed
Natus Medical announced today that it entered into a definitive agreement to acquire neurophysiology solution provider Micromed. Middleton, Wisconsin–based Natus expects the transaction to close in early 2023. The company elected not to disclose the financial terms of the deal. It marks the first transaction made by the company since its $1.2 billion acquisition by […]
ArchiMed completes $1.2B acquisition of Natus Medical
Natus Medical (Nasdaq:NTUS) announced today that ArchiMed’s investment firm completed its previously announced acquisition of the company. In April, the company announced that the MED Platform II fund of ArchiMed — an investment firm focused on the healthcare industry — would acquire Natus, a developer of medical devices for screening, diagnosing and treating disorders affecting […]
Archimed Group to acquire Natus Medical for $1.2B
Natus Medical today announced that it entered a definitive agreement to be acquired by Archimed for a total equity value of $1.2 billion. Through the agreement, Natus shareholders will receive $33.50 in cash for each share of Natus common stock to represent a 29% premium to the stock’s close price on April 14. “The sale […]
Natus Medical beats the Street in Q4, announces business realignment
Natus Medical (NSDQ:NTUS) this week posted fourth-quarter results that beat the overall consensus on Wall Street. The Pleasanton, California-based company makes devices and software to diagnose, monitor and treat brain and nervous system disorders. It reported profits of $1.7 million, or 5¢ per share, on sales of $128.7 million for the three months ended Dec. […]
Natus Medical appoints new president and CEO
Natus Medical recently announced that it appointed Thomas Sullivan as president and CEO, effective December 27. Sullivan previously served as president and CEO of medical device global contract manufacturer Spectrum Plastics. He has also held numerous leadership roles at A&E Medical, Symmetry Surgical and Symmetry Medical. In addition, he held executive positions at Johnson & […]
